Canadian Partnership Against Cancer
 

 
ENGLISH  |  FRANÇAIS
 
 
SHARE: twt fb yt
 
OCTOBER 2016
 
IN BRIEF
 
JOIN US FOR THE INNOVATIVE APPROACHES TO OPTIMAL CANCER CARE IN CANADA CONFERENCE
 
Registration and a Call for Abstracts are now open for the Innovative Approaches to Optimal Cancer Care in Canada conference, a one-of-a-kind opportunity to connect with cancer colleagues from across Canada and learn about innovations in cancer care.

Join us April 7-8, 2017 in Toronto and hear from renowned international and Canadian speakers who will inspire you with insights that span the cancer care continuum and delve into key themes:
  • Quality of care for all
  • Diagnostic process: A clear pathway or a revolving door?
  • Overcoming inertia in the cancer system: Why don't we do what we know works?
Confirmed international keynote speakers include:
  • Dr. Eric Schneider, United States: Principles and challenges of quality improvement initiatives
  • Dr. Greg Rubin, United Kingdom: Streamlining the early diagnostic process
  • Dr. David Currow, Australia: Why are we not applying what we know?
Follow the Partnership @CancerStratCA using #IAOCancer for updates about the conference.

Read More
 
2016 WORLD CANCER CONGRESS TO SHOWCASE GLOBAL CANCER CONTROL INNOVATIONS
The global cancer community will convene October 31-November 3 at the 2016 World Cancer Congress. Organized by the Union for International Cancer Control (UICC), the World Cancer Congress is a unique opportunity for the global cancer and wider health community to share innovations and best practices, develop meaningful collaborations and drive change together. The Partnership will highlight its work and progress underway on the international stage, and leverage the expertise that exists around the world to create measurable impacts within Canada.

Canada's coordinated approach to cancer control will be in the spotlight at the congress. The Canadian Partnership Against Cancer will present posters and participate in panels to share lessons learned and key developments in our efforts to reduce the burden of cancer on Canadians. This includes embedding a person-centred perspective in the cancer experience, forging “pathways to policy” that help include activity in urban design, cancer innovations with and for Indigenous peoples and ways to raise awareness and overcome taboos when setting up colorectal screening programs.

The Partnership will also lead two master classes focusing on integrating smoking cessation with cancer treatment and cancer system performance measurement and reporting.

Follow the Partnership on Twitter @CancerStratCA and on Facebook for live updates throughout the conference.

Read More
 
EXPLORE CANADA'S CANCER DATA LANDSCAPE THROUGH E‑LEARNING
Health care data is collected and stored in various locations across the country, such as hospitals, cancer centres, community pharmacies and provincial and national cancer registries. As a result, it can be difficult to analyze all the components and data associated with Canada's cancer system. The Canadian Partnership Against Cancer's new Analytic Capacity Building e-Learning module will help data analysts, epidemiologists and biostatisticians to increase their understanding of the Canadian cancer landscape.

The Cancer Registry Landscape in Canada, the first in a series of e-learning modules, is designed to provide participants with a foundation of information and create a common understanding of the cancer data landscape.

The Partnership's Analytic Capacity Building initiative is designed to enhance and create new capacity to support analysis and use of evidence to improve the cancer system and enable consistent pan-Canadian reporting related to cancer treatment.

Read More
 
CANADIAN CANCER STATISTICS 2016 SHOWS SHARP RISE IN MOUTH AND THROAT CANCERS AMONG MEN
The 2016 edition of Canadian Cancer Statistics, released October 19 by the Canadian Cancer Society, provides updated estimates of the state of cancer in Canada with a special focus on human papillomavirus (HPV)-related cancers. According to the report, cancers of the mouth and throat caused by HPV are rising dramatically among Canadian men and are poised to surpass the rate of cervical cancer in females.

Chapter 7 of the publication presents projections of the future impact of different prevention scenarios on the burden of cervical cancer, generated by the Partnership's OncoSim model (formerly known as the Cancer Risk Management Model). OncoSim modeling found that cervical cancer incidence and mortality could decrease by 2036 with moderate to high HPV vaccination rates among girls. Findings from OncoSim also point to lower costs associated with an age-based, sequential screening strategy of Pap testing followed by HPV testing compared to a Pap only strategy.

Read More
 
IPSOS SURVEY SHOWS CANADIANS STRONGLY SUPPORT ACCESS TO HIGH QUALITY PALLIATIVE CARE
An Ipsos survey commissioned by Palliative Care Matters with funding from the Canadian Partnership Against Cancer shows that Canadians strongly support access to high quality palliative care.

Palliative Care Matters is a national initiative that aims to further the development of a national palliative care strategy through a three part process that includes gathering input from the public and experts through research, holding a Consensus Development Conference in November, and issuing a report from the Conference Board of Canada outlining policy options and possible implementation plans in early 2017.

The Ipsos survey results are an essential part of the evidence that a lay panel of Canadians will weigh in on at the Consensus Development Conference being held in Ottawa on November 7-9, 2016. Professionals, patients and caregivers from across Canada are invited to speak up and have their points of view represented at the conference. Visit www.palliativecarematters.ca to register.

Read More
 
 
 
 
Canadian Partnership Against Cancer
1 ‌University Ave. Suite 30‌0 Toronto, Ontario M5‌J 2P‌1 Canada
 
 
 
 
Unsubscribe  |  Privacy policy  |  Subscribe

Production of this publication has been made possible through a financial contribution from
Health Canada, through the Canadian Partnership Against Cancer. The views expressed herein
represent the views of the Canadian Partnership Against Cancer.
 
CANADIAN PARTNERSHIP AGAINST CANCER